NaI-IRI
Showing 1 - 25 of 88
Triple Negative Breast Cancer, Brain Metastases Trial in Saint Louis (Pembrolizumab, Liposomal Irinotecan)
Recruiting
- Triple Negative Breast Cancer
- Brain Metastases
- Pembrolizumab
- Liposomal Irinotecan
-
Saint Louis, MissouriWashington University School of Medicine
Jun 1, 2022
Adenocarcinoma Metastatic, Biliary Tract Cancer, Adenocarcinoma of the Biliary Tract Trial in Ulm (Arm NaI-IRI + 5-FU +
Active, not recruiting
- Adenocarcinoma Metastatic
- +6 more
- Arm NaI-IRI + 5-FU + Leucovorin (Arm A)
- Arm Cisplatin + Gemcitabine (Arm B)
-
Ulm, GermanyUniversitätsklinikum Ulm
Apr 28, 2021
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)
Active, not recruiting
- Oncology
- Neuroendocrine Carcinoma
- Liposomal Irinotecan
- +3 more
-
Glasgow, United Kingdom
- +3 more
Dec 2, 2022
GEP-NET Trial in Taiwan (nanoliposomal irinotecan plus carboplatin)
Not yet recruiting
- GEP-NET
- nanoliposomal irinotecan plus carboplatin
-
Kaohsiung, Taiwan
- +5 more
May 17, 2022
Metastatic Pancreatic Cancer Trial in Amsterdam (S1 + Nal-IRI, Nal-IRI+Leucovorin+5-FU)
Recruiting
- Metastatic Pancreatic Cancer
- S1 + Nal-IRI
- Nal-IRI+Leucovorin+5-FU
-
Amsterdam, NetherlandsAcademic Medical Center, Medical Oncology
Jan 14, 2021
Ischemia Reperfusion Injury Trial in Philadelphia (Conjugated Estrogen, Normal saline)
Recruiting
- Ischemia Reperfusion Injury
- Conjugated Estrogen
- Normal saline
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 22, 2022
Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)
Recruiting
- Peritoneal Carcinomatosis
- +7 more
- PIPAC with Nal-IRI
-
Ghent, East-Flanders, BelgiumUZ Ghent
Dec 28, 2022
RWE on mPDAC Long-term Survival After Treatment With Liposomal
Recruiting
- Pancreatic Cancer Metastatic
-
Munich, GermanyKlinikum der Universität München, - Anstalt des öffentlichen Rec
Nov 24, 2023
Landscape and Survival in Metastatic Pancreatic Cancer After
Recruiting
- Pancreatic Neoplasms
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 19, 2022
Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose
Recruiting
- Solid Tumor
- +6 more
- CM-24 and Nivolumab - Dose Escalation
- +4 more
-
Scottsdale, Arizona
- +10 more
Jan 17, 2023
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
Metastatic Pancreatic Cancer Trial in France, Martinique (Irinotecan Liposomal Injection, 5-FU/LV, Nab-Paclitaxel)
Recruiting
- Metastatic Pancreatic Cancer
- Irinotecan Liposomal Injection
- +3 more
-
Amiens, France
- +35 more
Mar 23, 2022
Liver Diseases Trial (pneumatic tourniquet, No inflation)
Completed
- Liver Diseases
- pneumatic tourniquet
- No inflation
-
Lille, FranceHop Claude Huriez Chu Lille
Oct 14, 2022
Myocardial Reperfusion Injury, Hypoxia, Hyperoxia Trial (Hypoxic-hyperoxic preconditioning, Placebo)
Completed
- Myocardial Reperfusion Injury
- +3 more
- Hypoxic-hyperoxic preconditioning
- Placebo
- (no location specified)
May 6, 2022
Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)
Recruiting
- Breast Cancer Metastatic
- Irinotecan Hydrochloride
-
Badalona, Spain
- +19 more
Jan 18, 2023
Diagnosis of Ischemic Heart Disease Determined by Fraction Flow
Recruiting
- Coronary Artery Disease
-
Beijing, Beijing, ChinaFuwai Hospital
Sep 7, 2023
Pancreas Cancer Trial in Seoul (Vactosertib)
Recruiting
- Pancreas Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
EPIPAGE 2 - 10-year Follow-up (RECONAI PROJECT)
Not yet recruiting
- Pre-Term
- Development, Child
- (no location specified)
Feb 16, 2022
Liver Transplantation Trial in France (temporary porto-caval shunt)
Recruiting
- Liver Transplantation
- temporary porto-caval shunt
-
Bordeaux, France
- +4 more
Apr 29, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Anyang, Seoul (NASOX)
Recruiting
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
-
Anyang, Gyeonggi, Korea, Republic of
- +1 more
Jul 16, 2021
Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))
Not yet recruiting
- Metastatic Pancreatic Cancer
- Low Dose OXIRI (LD-OXIRI)
-
Singapore, SingaporeNational Cancer Centre, Singapore
Jun 29, 2023
Colon Cancer, Rectal Cancer Trial in United States (TAS-102, oxaliplatin, irinotecan with bevacizumab)
Not yet recruiting
- Colon Cancer
- Rectal Cancer
- TAS-102, oxaliplatin, irinotecan with bevacizumab
-
Elizabeth, New Jersey
- +6 more
Apr 7, 2023